George MacKenzie - Safeguard Scientifics Independent Director
| SFEDelisted Stock | USD 0.46 0.19 29.23% |
Director
Mr. George MacKenzie is Independent Director of Safeguard Scientifics, Inc. He served as Interim Chief Executive Officer, American Water Works Company, Inc., a provider of water services in North America . Interim Chief Executive Officer, CD Technologies, Inc., a technology company that markets systems for the conversion and storage of electrical power . Executive Vice President and Chief Financial Officer, P.H. Glatfelter Company, a manufacturer of specialty papers and engineered products . Vice Chairman and Chief Financial Officer of, and several other executive positions during his 22year career with, Hercules, Incorporated, a global chemical specialties manufacturer. since 2003.
| Age | 68 |
| Tenure | 21 years |
| Phone | 610-293-0600 |
| Web | https://www.safeguard.com |
Safeguard Scientifics Management Efficiency
The company has Return on Asset of (0.0778) % which means that on every $100 spent on assets, it lost $0.0778. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2938) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics' management efficiency ratios could be used to measure how well Safeguard Scientifics manages its routine affairs as well as how well it operates its assets and liabilities.The company has 1.68 M in debt with debt to equity (D/E) ratio of 0.04, which may show that the company is not taking advantage of profits from borrowing. Safeguard Scientifics has a current ratio of 18.08, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Safeguard Scientifics until it has trouble settling it off, either with new capital or with free cash flow. So, Safeguard Scientifics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Safeguard Scientifics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Safeguard to invest in growth at high rates of return. When we think about Safeguard Scientifics' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Simms Browning | Central Securities | 78 | |
| Peter Anderson | Flow Capital Corp | N/A | |
| Eldon Smith | Flow Capital Corp | 74 | |
| Joachim Wagner | European Equity Closed | 67 | |
| Paola Mungo | Azimut Holding SpA | 48 | |
| Franz Hopp | Central Europe Russia | 71 | |
| Andre Bineau | Flow Capital Corp | 74 | |
| Martin Burian | Elysee Development Corp | N/A | |
| Christopher Pleister | Central Europe Russia | 72 | |
| Richard Goeltz | Central Europe Russia | 71 | |
| Real Bellemare | Fiera Capital | N/A | |
| David Shaw | Fiera Capital | 63 | |
| Detlef Bierbaum | Central Europe Russia | 74 | |
| Brian Davis | Fiera Capital | N/A | |
| Sabrina Liak | Mount Logan Capital | N/A | |
| Wolfgang Leoni | Central Europe Russia | 62 | |
| Gordon McMillan | Flow Capital Corp | 45 | |
| Richard Goeltz | European Equity Closed | 75 | |
| Friedbert Malt | Central Europe Russia | 73 | |
| Charles Heath | Tortoise Mlp Closed | 75 | |
| David Colander | Central Securities | 71 | |
Management Performance
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0778 |
Safeguard Scientifics Leadership Team
Elected by the shareholders, the Safeguard Scientifics' board of directors comprises two types of representatives: Safeguard Scientifics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Safeguard. The board's role is to monitor Safeguard Scientifics' management team and ensure that shareholders' interests are well served. Safeguard Scientifics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Safeguard Scientifics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julie Dobson, Independent Director | ||
| Ira Lubert, Independent Director | ||
| Russell Glass, Independent Director | ||
| Matthew Barnard, Secretary Counsel | ||
| Mark Herndon, Chief Financial Officer, Senior Vice President | ||
| Mark Dow, CFO CEO | ||
| David Kille, CFO | ||
| Alex Fuiks, Associate | ||
| Maureen Morrison, Independent Director | ||
| Albert II, Sr. VP and Managing Director of Healthcare | ||
| Scott Snyder, Senior Vice President Managing Director, Chief Technology and Innovation Officer | ||
| George MacKenzie, Independent Director | ||
| Jack Messman, Independent Director | ||
| John Shave, Vice President - Business Development and Corporate Communications | ||
| Eric Salzman, Chief Restructuring Officer | ||
| Stephen Zarrilli, President CEO, Director | ||
| Jeffrey McGroarty, CFO, Senior Vice President - Finance | ||
| Mark CPA, VP CFO | ||
| John Roberts, Independent Director | ||
| Robert Rosenthal, Executive Chairman of the Board, Principal Executive Officer | ||
| Stephen Fisher, Independent Director | ||
| Andrew Lietz, Independent Chairman of the Board | ||
| Seth Zuckerman, Associate Healthcare | ||
| Brian Sisko, Executive Vice President Managing Director | ||
| Mara Aspinall, Director | ||
| Joseph Manko, Independent Director |
Safeguard Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Safeguard Scientifics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.29 | |||
| Return On Asset | -0.0778 | |||
| Current Valuation | (4.6 M) | |||
| Shares Outstanding | 16.58 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 45.02 % | |||
| Number Of Shares Shorted | 208.05 K | |||
| Price To Earning | 23.06 X | |||
| Price To Book | 0.41 X | |||
| EBITDA | (7.36 M) |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Safeguard Stock
If you are still planning to invest in Safeguard Scientifics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Safeguard Scientifics' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |